A Description of the Pioneering Work That Led to the First Approved Agents for ED: Giles Brindley, the Needle, and the Penis (Phenoxybenzamine)
- … show all 0 hide
Although some earlier work had been described by Virag, this study really laid down the foundation for the use of therapeutics in the management of ED. It encouraged both patients and physicians to believe that there was a realistic alternative to corrective or implant surgery.
- Brindley G. Cavernosal alpha-blockade: a new technique for investigating and treating erectile dysfunction. Br J Psychiat 143:332–337, 1983.
- Virag R. Intracavernous injection of papaverine for erectile failure. Lancet ii, 938, 1982. CrossRef
- Brindley G. Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection. Br J Psychiat 149:210–215, 1986. CrossRef
- Keogh E, Earle C, et al. Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double-blind controlled trial. Aust NZ J Med 19(2):108–112, 1989.
- A Description of the Pioneering Work That Led to the First Approved Agents for ED: Giles Brindley, the Needle, and the Penis (Phenoxybenzamine)
- Book Title
- Key Clinical Trials in Erectile Dysfunction
- pp 4-7
- Print ISBN
- Online ISBN
- Springer London
- Copyright Holder
- Springer-Verlag London Limited
- Additional Links
- Industry Sectors
- eBook Packages
To view the rest of this content please follow the download PDF link above.